Fibralign Announces CE Mark Approval for BioBridge
Fibralign Corp., a Stanford spin-out and developer of therapeutic biomedical devices, today announced that it has received CE mark for its first product, the BioBridge® Collagen Matrix. Read More →
PhotoniCare Announces More Than $7M in Funding for Commercial Expansion of First-In-Class Ear Imaging Technology
PhotoniCare, Inc., a company dedicated to revolutionizing healthcare by providing physicians with better diagnostic tools, today announced an oversubscribed $5.2 million Series A financing led by i2E Management Company Inc., with co-investment from OSF Ventures, Sony Innovation Fund, and Dreampact Ventures. Read More →
Miracor Medical Raises €24M in Funding
Miracor Medical SA, an Awans, Belgium-based provider of innovative solutions for the treatment of severe cardiac diseases, closed a €24M Series E round of financing. Read More →
ODS Medical, Inc. closes a new financing round to further support product development diversification of applications
ODS Medical, Inc., a Montreal based medical technology company, is pleased to announce a new financing round to support product engineering and regulatory work. Read More →
CoapTech Raises $7M in Series B Funding Led by Hunniwell
CoapTech, a leading medical device start-up pioneering the world’s first and only ultrasound-based feeding tube placement system, announced the closing of a Series B investment of $7 million led by medical device venture capital firm Hunniwell Lake Ventures. They will use funds to commercialize the First FDA-cleared, Ultrasound-based system for Feeding Tube Placement. Read More →
Sidekick Health wins the eHealth Award 2020
The annual award was open for startups from all the Nordic countries for the first time this year. This year, Icelandic health company Sidekick Health ended up as winners after having been one of three finalists together with Swedish-Norwegian Boneproxand Swedish Cuviva. Read More →
LensGen® Closes $10 Million Financing and Welcomes James V. Mazzo to its Board of Directors
LensGen, Inc., an ophthalmic medical device company and developer of Juvene®, a disruptive fluid-optic intraocular lens (IOL) for cataract and presbyopia treatment, announces the initial Closing of a $10 million of the $20 million Bridge Financing. The company is also pleased to announce the election of James (Jim) Mazzo to its Board of Directors. Read More →
Money Moves: 3 life science and health IT companies raise funds — and one goes public (featuring Strados Labs)
Strados Labs has been awarded a National Science Foundation (NSF)Phase I Small Business Innovation Research grant for nearly $225,000 to conduct research on its wearable platform for remote respiratory monitoring. Read More →
Sentien Biotechnologies Announces Open IND in Phase 1/2 Trial of SBI-101 for Patients with COVID-19
Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application for the evaluation of Sentien’s lead asset, SBI-101, for the treatment of severe COVID-19. Read More →
Oncodisc, Inc. Awarded Competitive Grant from the National Science Foundation to Develop Cancer Technology
Oncodisc, Inc. today announced that it is the recipient of a competitive National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant award. Read More →